QRS Complex Detection Using Adaptive Lead Selection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional QRS complex detection methods in ECG data are inaccurate due to excessive muscle noise and artifacts during stress testing, leading to false negatives and false positives, especially when using single leads or global detection techniques like leads II, aVF, and V5.

Innovation Solution

The use of electrode leads II, V4, and V5 for QRS complex detection, combined with signal quality estimation to select the most appropriate leads, and a majority criterion to confirm QRS complex occurrence, improving detection accuracy and avoiding false determinations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional single lead or global detection techniques (leads II, aVF, V5) are used for QRS complex detection, then the detection process is simple, but the detection accuracy deteriorates due to excessive muscle noise and artifacts during stress testing

Engineering Contradiction:
ImproveQRS complex detection accuracyVSAvoidmuscle noise and artifacts
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent segments the QRS detection process into two distinct phases: an offline learning phase where normal QRS templates are acquired and stored, and an online detection phase where these templates are used for comparison. This segmentation allows the system to establish a reference baseline of normal QRS complexes free from stress-induced noise, which then serves as a filter during actual stress testing, improving detection accuracy despite the presence of muscle noise and artifacts.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent performs preliminary action by acquiring and storing normal QRS complex templates during a baseline period before stress testing begins. This preliminary template acquisition creates a reference database of what normal QRS complexes look like for each patient, which is then used during stress testing to identify and filter out false detections caused by muscle noise and artifacts, thereby improving detection accuracy.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If conventional detection methods are used, then the device complexity is low, but false negatives and false positives increase

Engineering Contradiction:
Improvedetection reliabilityVSAvoiddetection algorithm complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent implements feedback by continuously comparing detected QRS complexes against the stored normal templates and using the results to adjust detection thresholds and parameters. The system analyzes detection outcomes and feeds this information back into the detection algorithm, allowing it to adapt to individual patient variations and stress conditions, thereby reducing false negatives and false positives while maintaining manageable complexity through automated adjustment rather than complex manual configuration.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent applies parameter changes by dynamically adjusting detection thresholds, time windows, and amplitude criteria based on the patient's baseline characteristics stored in the normal QRS templates. Instead of using fixed detection parameters, the system modifies these parameters according to the individual patient's normal ECG patterns, improving reliability by adapting to patient-specific variations while keeping the overall algorithm structure relatively simple.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS10285613B2Apparatus and method for determining the occurrence of a QRS complex in ECG data
Publication Date: 2019.05.14 KONINKLIJKE PHILIPS NV
  • US10285613B2 patent drawing
  • US10285613B2 patent drawing
  • US10285613B2 patent drawing

AI summary

The present invention provides apparatus and a method for determining the occurrence of a QRS complex in ECG data. According to an aspect of the present invention, an apparatus is proposed for determining the occurrence of a QRS complex in ECG data by utilizing a first, second and third set of ECG data that are acquired by respectively electrode leads II, V4 and V5 and by determining whether a QRS complex has been detected within the predefined temporal window in at least two of the first, second and third sets of ECG data. According to another aspect of the present invention, an apparatus is proposed for determining the occurrence of a QRS complex in ECG data by utilizing three sets of ECG data whose signal quality values V are the smallest three of the first to twelfth sets of ECG data that are acquired by respectively the standard 12 electrode leads and by determining whether a QRS complex has been detected within the predefined temporal window in at least two of the three sets of ECG data. The two apparatus of the present invention may improve the accuracy of QRS detection, which has been proved by clinical testing.